Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.49SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.67SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.190SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.120SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AM.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AA.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.249SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AA.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.505SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.406SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.115SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AA.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AT.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.619.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.1.12.1 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AZ.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.260SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.456SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.4.16 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.70SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.42SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.374SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.63 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.377SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.258.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.30.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.76SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.385SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.384SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.32SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.338SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BG.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XVSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.80SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.134SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BY.1.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BM.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BM.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XAY.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBC.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used